BioWorld MedTech

Feb. 25, 2011

Deals roundup: Thermo Fisher in plan to sell diagnostic labs for $940M

Thermo Fisher Scientific (Waltham, Massachusetts) reported that it has signed definitive agreements to sell Athena Diagnostics (Worcester, Massachusetts) to Quest Diagnostics (Madison, New Jersey) for $740 million. (Medical Device Daily) Read More

Cook launches EchoTip ProCore, new histology needle for EUS

International report: Mazor's PIPE dreams up $6.3M in new capital funds for company

RFID Hospial Smart Room uses real-time patient data

Agreements/contracts: Masimo to license Pulse for Royal Fornia monitors

MDD's food for med-tech thought

New ventures: Biolase Technology forms new imaging business unit

Clarification

Product Briefs

HIT roundup: Lumedx launches Enabling EHR suite for meaningful use

People in the News

MDD's Diagnostic Extra

Today's news in brief

BioWorld

BioWorld briefs for April 8, 2025.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for April 8, 2025.

Caution tape displaying US flag, tariffs

Biopharma exempt from US reciprocal tariffs, but not untouched

BioWorld

At first glance, it appears that biopharmaceuticals dodged the latest U.S. tariff bullet; med-tech, not so much. According to the executive order President Donald...

Many med-tech company supply chains protected from tariffs

BioWorld MedTech

In the wake of the pandemic, many leading med-tech companies took steps to on-shore and near-shore manufacturing, a move that could protect significant numbers of...

3D rendering of glucagon-like peptide 1 (GLP-1)

ADPD 2025: Unlocking GLP-1's potential in neurodegeneration

BioWorld

At the recently launched Alzheimer’s & Parkinson’s Diseases Conference held in Vienna, Lotte Bjerre Knudsen from Novo Nordisk A/S, who has extensive experience in...